V540C Vaccine Study in Healthy Adults

We are investigating the V540C vaccine to see how it works in healthy adults. This study aims to assess its safety and immune response.

1-2 yearsSafety phase (I)Infectious DiseasesOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Universitair Ziekenhuis Gent
DRUG
Ledeberg, Belgium
Advanced Technology Corporation
Clinical Pharmacology Unit/A.T.C.
Tilff, Belgium
SGS Belgium
SGS Clinical Pharmacology Unit
Wilrijk, Belgium
Sponsor: Merck Sharp & Dohme LLC
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.